Literature DB >> 21358694

Cardiovascular disease: World Kidney Day 2011: protect your kidneys, save your heart.

William G Couser, Miguel C Riella.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21358694     DOI： 10.1038/nrneph.2011.11

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  9 in total

1.  Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population.

Authors:  Hans L Hillege; Vaclav Fidler; Gilles F H Diercks; Wiek H van Gilst; Dick de Zeeuw; Dirk J van Veldhuisen; Rijk O B Gans; Wilbert M T Janssen; Diederick E Grobbee; Paul E de Jong
Journal:  Circulation       Date:  2002-10-01       Impact factor: 29.690

2.  Prevalence of chronic kidney disease in elderly patients with normal serum creatinine levels undergoing percutaneous coronary interventions.

Authors:  J Malyszko; H Bachorzewska-Gajewska; J S Malyszko; S Dobrzycki
Journal:  Gerontology       Date:  2009-12-09       Impact factor: 5.140

3.  Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis.

Authors:  Kunihiro Matsushita; Marije van der Velde; Brad C Astor; Mark Woodward; Andrew S Levey; Paul E de Jong; Josef Coresh; Ron T Gansevoort
Journal:  Lancet       Date:  2010-05-17       Impact factor: 79.321

4.  Albuminuria is a target for renoprotective therapy independent from blood pressure in patients with type 2 diabetic nephropathy: post hoc analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial.

Authors:  Wouter B A Eijkelkamp; Zhongxin Zhang; Giuseppe Remuzzi; Hans-Henrik Parving; Mark E Cooper; William F Keane; Shahnaz Shahinfar; Gilbert W Gleim; Matthew R Weir; Barry M Brenner; Dick de Zeeuw
Journal:  J Am Soc Nephrol       Date:  2007-04-04       Impact factor: 10.121

5.  Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria.

Authors:  Folkert W Asselbergs; Gilles F H Diercks; Hans L Hillege; Ad J van Boven; Wilbert M T Janssen; Adriaan A Voors; Dick de Zeeuw; Paul E de Jong; Dirk J van Veldhuisen; Wiek H van Gilst
Journal:  Circulation       Date:  2004-10-18       Impact factor: 29.690

6.  Relation between kidney function, proteinuria, and adverse outcomes.

Authors:  Brenda R Hemmelgarn; Braden J Manns; Anita Lloyd; Matthew T James; Scott Klarenbach; Robert R Quinn; Natasha Wiebe; Marcello Tonelli
Journal:  JAMA       Date:  2010-02-03       Impact factor: 56.272

7.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.

Authors:  Alan S Go; Glenn M Chertow; Dongjie Fan; Charles E McCulloch; Chi-yuan Hsu
Journal:  N Engl J Med       Date:  2004-09-23       Impact factor: 91.245

8.  Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population.

Authors:  Brad C Astor; Stein I Hallan; Edgar R Miller; Edwina Yeung; Josef Coresh
Journal:  Am J Epidemiol       Date:  2008-04-02       Impact factor: 4.897

9.  Renal insufficiency and mortality in patients with known or suspected coronary artery disease.

Authors:  Ron T van Domburg; Sanne E Hoeks; Gijs M J M Welten; Michel Chonchol; Abdou Elhendy; Don Poldermans
Journal:  J Am Soc Nephrol       Date:  2008-01       Impact factor: 10.121
  9 in total
  2 in total

1.  Garlic (Allium sativum) exhibits a cardioprotective effect in experimental chronic renal failure rat model by reducing oxidative stress and controlling cardiac Na+/K+-ATPase activity and Ca2+ levels.

Authors:  Asmaa M S Gomaa; Alaa T Abdelhafez; Hazem A Aamer
Journal:  Cell Stress Chaperones       Date:  2018-04-21       Impact factor: 3.667

2.  Failure to downregulate the epithelial sodium channel causes salt sensitivity in Hsd11b2 heterozygote mice.

Authors:  Eilidh Craigie; Louise C Evans; John J Mullins; Matthew A Bailey
Journal:  Hypertension       Date:  2012-07-09       Impact factor: 10.190
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.